Kinase inhibitor (MET inhibitor)
Tepmetko Tablet (tepotinib) treats metastatic NSCLC with MET exon 14 skipping alterations. Learn about dosage, side effects, and warnings.
Tabrecta Tablet (capmatinib) treats advanced NSCLC with MET exon 14 skipping mutations. Learn uses, dosage, side effects, and precautions here.